CTSO
HEALTHCARECytosorbents Corp
$0.57-0.04 (-5.80%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CTSO Today?
No stock-specific AI insight has been generated for CTSO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.50$1.39
$0.57
Fundamentals
Market Cap$38M
P/E Ratio—
EPS$-0.13
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume115K
Avg Volume (10D)—
Shares Outstanding62.8M
CTSO News
20 articles- CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business HighlightsYahoo Finance·Apr 30, 2026
- CTSO: CytoSorbents Reports Strong 4th Quarter and Full Year 2025 ResultsYahoo Finance·Apr 6, 2026
- Cytosorbents (CTSO) Q4 2025 Earnings TranscriptMotley Fool·Mar 26, 2026
- Cytosorbents Corporation Q4 2025 Earnings Call SummaryMoby·Mar 26, 2026
- CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ...Yahoo Finance·Mar 26, 2026
- CytoSorbents: Q4 Earnings SnapshotYahoo Finance·Mar 25, 2026
- CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business HighlightsYahoo Finance·Mar 25, 2026
- CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026Yahoo Finance·Mar 19, 2026
- CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business HighlightsYahoo Finance·Mar 5, 2026
- Analysts Expect Breakeven For Cytosorbents Corporation (NASDAQ:CTSO) Before LongYahoo Finance·Feb 14, 2026
- CTSO: CytoSorbents Price Target Increased to $5.00 Based on Higher Than Expected Gross MarginsYahoo Finance·Jan 13, 2026
- CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business UpdateYahoo Finance·Jan 12, 2026
- CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025Yahoo Finance·Dec 10, 2025
- Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in LondonYahoo Finance·Nov 17, 2025
- CTSO: CytoSorbents High Margin Revenue Growth Supports Price Target of $4.00Yahoo Finance·Nov 17, 2025
- CytoSorbents Corp (CTSO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...Yahoo Finance·Nov 14, 2025
- Cytosorbents (CTSO) Q3 2025 Earnings TranscriptMotley Fool·Nov 13, 2025
- CytoSorbents: Q3 Earnings SnapshotYahoo Finance·Nov 13, 2025
- CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business UpdateYahoo Finance·Nov 13, 2025
- CytoSorbents to Participate at the Jefferies Global Healthcare Conference in LondonYahoo Finance·Nov 11, 2025
All 20 articles loaded
Price Data
Open$0.00
Previous Close$0.61
Day High$0.00
Day Low$0.00
52 Week High$1.39
52 Week Low$0.50
52-Week Range
$0.50$1.39
$0.57
Fundamentals
Market Cap$38M
P/E Ratio—
EPS$-0.13
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume115K
Avg Volume (10D)—
Shares Outstanding62.8M
About Cytosorbents Corp
Cytosorbents Corporation, a critical care focused immunotherapy company, is dedicated to the research, development and commercialization of medical devices with its blood purification technology platform incorporating proprietary adsorbent and porous polymer technology. The company is headquartered in Monmouth Junction, New Jersey.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—